KRAS and lung carcinoma: KRAS mutations are usually not associated with mutations of other drivers of lung cancer development, ALK and ROS1; however, co-mutations of KRAS and other genes such as TP53, STK11, KEAP1 and NFE2L2 are more frequent (61).